Tenet Healthcare (NYSE:THC) Issues FY 2026 Earnings Guidance

Tenet Healthcare (NYSE:THC) issued an update on its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 20.300-21.690 for the period, compared to the consensus estimate of 17.810. The company issued revenue guidance of $21.9 billion-$22.5 billion, compared to the consensus revenue estimate of $22.0 billion.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on THC. Weiss Ratings cut Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 2nd. KeyCorp decreased their price objective on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Guggenheim cut their target price on shares of Tenet Healthcare from $252.00 to $242.00 and set a “buy” rating for the company in a research note on Monday. Wells Fargo & Company lifted their target price on shares of Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Finally, Robert W. Baird decreased their target price on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. Seventeen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $244.84.

Tenet Healthcare Stock Performance

NYSE THC traded up $4.50 during trading on Thursday, reaching $199.85. The company’s stock had a trading volume of 1,767,793 shares, compared to its average volume of 1,248,933. Tenet Healthcare has a 12 month low of $146.60 and a 12 month high of $247.21. The firm has a 50 day moving average price of $184.41 and a 200 day moving average price of $197.37. The firm has a market capitalization of $17.22 billion, a price-to-earnings ratio of 10.39, a price-to-earnings-growth ratio of 1.63 and a beta of 1.27. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business had revenue of $5.63 billion during the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, equities analysts anticipate that Tenet Healthcare will post 17.5 EPS for the current fiscal year.

Insider Activity

In other news, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total transaction of $532,050.00. Following the sale, the director directly owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the transaction, the director directly owned 16,804 shares of the company’s stock, valued at $2,932,634.08. This represents a 25.12% decrease in their position. The SEC filing for this sale provides additional information. 0.97% of the stock is currently owned by company insiders.

Institutional Trading of Tenet Healthcare

A number of large investors have recently bought and sold shares of THC. Triumph Capital Management acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at about $25,000. Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare during the second quarter worth approximately $35,000. Meeder Asset Management Inc. grew its position in shares of Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after buying an additional 114 shares during the period. Geneos Wealth Management Inc. lifted its position in shares of Tenet Healthcare by 50.9% during the 2nd quarter. Geneos Wealth Management Inc. now owns 264 shares of the company’s stock valued at $46,000 after acquiring an additional 89 shares during the period. Finally, Wilkerson Advisory Group LLC bought a new position in Tenet Healthcare during the fourth quarter worth $62,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.